Pfizer and BioNTech announced updated data for Omicron BA.4/BA.5-adapted bivalent booster
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…
On Nov. 3, 2022, the University of Missouri announced a $1.5 million gift from the Orthopedic Foundation for…
On Nov. 2, 2022, AIM ImmunoTech announced that the U.S. Food and Drug Administration had granted Orphan Drug…
On Nov. 1, 2022, the U.S. Department of Agriculture announced it was making $30 million in American Rescue…
On Nov. 1, 2022, Pfizer announced positive top-line data from the Phase 3 clinical trial (NCT04424316) MATISSE (MATernal…
On Nov. 1, 2022, study results published in JAMA found that estimates in this cross-sectional study of 694,660…
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
On Sept. 3, 2014, the Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,…
On Oct. 27, 2022, the World Health Organization reported that an estimated 10.6 million people fell ill with…
On Oct. 26, 2022, the NIH announced it had awarded the University of Southern California (USC) $11.7 million…
On Oct. 25, 2022, the University of Washington reported that daily global COVID-19 infections were projected to rise…
On Oct. 25, 2022, the National Institutes of Health (NIH) announced that the University of Missouri had been…
On Oct. 24, 2022, Merck announced that the European Commission had approved an expanded indication for VAXNEUVANCEル (Pneumococcal…
On Oct. 20, 2022, newly published results supported previous findings that the recombinant zoster vaccine Shingrix, recommended by…
On Oct. 19, 2022, Pfizer and BioNTech announced that the European Medicines Agencyメs (EMA) Committee for Medicinal Products…
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
On Oct. 13, 2022, researchers from the University of Oxford reported findings from a study exploring how certain…
On Oct. 12, 2022, scientists announced they had developed a research method that allows for a much more…
On Oct. 11, 2022, Roche announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (モ2.0ヤ) for…
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
On Oct. 7, 2022, the U.S. Food and Drug Administration approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and…
On Oct. 7, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorizationto Abbott Molecular, Inc.,…
On Oct. 7, 2022, the National Eye Institute researchers announced they had mapped the organization of human retinal…
On Oct. 6, 2022, Merck announced data from two real-world evidence studies evaluating LAGEVRIOル (molnupiravir), an investigational oral…
On Oct. 6, 2022, the World Health Organization announced the first cholera outbreak in nearly three decades in…
On Oct. 5, 2022, researchers at UC Berkeley reported that coccidioidomycosisラalso known as Valley feverラan infectious disease, was…
On Oct. 5, 2022, the Nobel Prize in Chemistry was awarded jointly to Carolyn R. Bertozzi, Morten Meldal…
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….